米国のディスポーザブルシリンジ市場規模、シェア、動向分析レポート：製品別、用途別、セグメント予測、2024-2030年

米国のディスポーザブルシリンジ市場の成長と動向

Grand View Research, Inc.の最新レポートによると、米国のディスポーザブルシリンジ市場規模は2030年までに36億9,000万米ドルに達すると予測されています。

予測期間中のCAGRは5.5％と予測されています。同市場は、ワクチン需要の増加に加え、薬剤の自己投与の採用拡大、安全注射器の採用拡大、技術進歩が米国のディスポーザブルシリンジ市場の成長を支えています。

SARS-CoV-2パンデミックは、病院用品、救急用品、医療消耗品、医薬品の需要を大幅に増加させました。COVID-19の影響で、COVID-19ワクチンの生産が増加し、米国製のディスポーザブルシリンジの需要が増加しています。2020年1月には、米国だけでも、ワクチン接種に6億5,000万～8億5,000万本の注射針と注射器が必要になるとBiomedical Advanced Research and Development Authority（BARDA）は予測しています。したがって、COVID-19の発生は医療用ディスポーザブルシリンジ市場に多大な影響を与えており、米国のディスポーザブルシリンジ市場の非常に効果的な促進要因であると考えられています。

今後、国連児童基金（UNICEF）のような組織は、COVID-19施設国におけるCOVID-19予防接種活動のために、2021年末までに10億本の注射器を購入することを目標としています。このシリンジはすべて、世界保健機関（WHO）が許可するオートディスアブル（AD）タイプになります。その結果、市場の成長は近い将来加速すると予想されます。

米国のディスポーザブルシリンジ市場レポート・ハイライト

• 製品別では、ディスポーザブルシリンジ市場は従来型注射器と安全注射器に区分されます。安全注射器セグメントは2023年に約64.5%の最大シェアを占め、この製品に関連する安全性や使いやすさなどの様々な利点により、予測期間中に大きな成長が見込まれます。
• 用途別では、治療用注射器分野が2023年に約86.2％の最大市場シェアを占めたが、これは献血に対する意識の高まりと、HIV感染症、結核マラリア、デング熱などの疾病の国内有病率の高さによるものです。
• カリフォルニアのディスポーザブルシリンジ市場は、予測期間中に最も速い成長率を示すと予想されています。市場成長の要因としては、老人人口の増加、手術件数の増加、ヘルスケアへの支出の増加などが挙げられます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ディスポーザブルシリンジ市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 補助市場の見通し
• 浸透と成長の見込みマッピング
• ユーザーの視点分析
  • 消費者行動分析
  • 市場インフルエンサー分析
• 主要エンドユーザーのリスト
• 市場力学
  • 市場 促進要因分析
  • 市場抑制要因分析
• ディスポーザブルシリンジ：市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • SWOT分析、PEST別
• COVID-19が市場に与える影響とパンデミック後の展望

第4章 米国のディスポーザブルシリンジ市場：セグメント分析、製品別、2018年-2030年

• 定義と範囲
• 製品市場シェア分析、2023年および2030年
• セグメントダッシュボード
• 米国のディスポーザブルシリンジ市場、製品別、2018～2030年
• 市場規模と予測および動向分析、2018年から2030年
• 従来型シリンジ
• 安全シリンジ

第5章 米国のディスポーザブルシリンジ市場： セグメント分析、用途別、2018年-2030年

• 定義と範囲
• 用途市場シェア分析、2023年および2030年
• セグメントダッシュボード
• 米国のディスポーザブルシリンジ市場、用途別、2018～2030年
• 市場規模と予測および動向分析、2018年から2030年
• 予防接種注射
• 治療注射

第6章 米国のディスポーザブルシリンジ市場- 競合分析

• 主要市場参入企業による最近の動向と影響分析
• 企業分類
  • イノベーター
  • マーケットリーダー
• ベンダー情勢
• 企業プロファイル
  • Medtronic
  • Nipro Corporation
  • Fresenius Kabi Ag
  • Baxter International, Inc.
  • Braun Medical, Inc.
  • Becton, Dickinson And Company（Bd）
  • Flextronics International Vita Needle Company
  • Terumo Corporation
  • Novo Nordisk
  • Ultimed, Inc.
  • Henke-sass, Wolf
  • Retractable Technologies, Inc.

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. disposable syringes market, by product, 2018 - 2030 (USD Million)
• Table 4 U.S. disposable syringes market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Disposable syringes market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2021)
• Fig. 10 Segment outlook
• Fig. 11 Strategy framework
• Fig. 12 Penetration & growth prospect mapping
• Fig. 13 Consumer behavior analysis
• Fig. 14 Market driver relevance analysis (Current & future impact)
• Fig. 15 Market restraint relevance analysis (Current & future impact)
• Fig. 16 Porter's five forces analysis
• Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 18 Disposable syringes market: Product movement analysis
• Fig. 19 Segment dashboard
• Fig. 20 Disposable syringes market product outlook: Key takeaways
• Fig. 21 Conventional syringes market, 2018 - 2030 (USD Million)
• Fig. 22 Safety syringes market, 2018 - 2030 (USD Million)
• Fig. 23 Retractable safety syringes market, 2018 - 2030 (USD Million)
• Fig. 24 Non-retractable safety syringes market, 2018 - 2030 (USD Million)
• Fig. 25 Disposable syringes market: Application movement analysis
• Fig. 26 Segment dashboard
• Fig. 27 Disposable syringes market application outlook: Key takeaways
• Fig. 28 Immunization injections market, 2018 - 2030 (USD Million)
• Fig. 29 Therapeutic injections market, 2018 - 2030 (USD Million)
• Fig. 30 Company market share analysis, 2021
• Fig. 31 Market differentiators

U.S. Disposable Syringes Market Growth & Trends:

The U.S. disposable syringes market size is expected to reach USD 3.69 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a 5.5% CAGR over the forecast period. The market is expected to grow due to increasing demand for vaccines along with growing adoption of self-administration of drugs, increasing adoption of safety syringes, and technological advancements, are supporting the market growth of U.S. disposable syringes.

The COVID-19 pandemic is anticipated to have a significant effect on the disposable syringe business in the U.S. The SARS-CoV-2 pandemic has caused a considerable increase in demand for hospital supplies, emergency supplies, medical disposables, and medications. Due to COVID-19, there has been an increase in COVID-19 vaccine production, which has led to an increase in demand for disposable syringes made in the U.S. In January 2020, in the U.S. alone, the Biomedical Advanced Research and Development Authority (BARDA) projected that 650 million to 850 million needles and syringes would be required to administer a vaccination. Therefore, the COVID-19 outbreak has immensely impacted medical disposables market and is considered to be a highly effective driver for U.S. disposable syringes market.

Moving forward, organizations like United Nations Children's Fund (UNICEF) aimed to purchase 1 billion syringes by the end of 2021 for COVID-19 vaccination operations in COVAX Facility nations. The syringes will all be of the auto-disable (AD) type, as permitted by the World Health Organization, notwithstanding the fact that the vaccines secured by the Facility may vary in their composition and storage needs. As a result, market growth is expected to accelerate in the near future.

U.S. Disposable Syringes Market Report Highlights:

• On the basis of product, disposable syringes market has been segmented into conventional and safety syringes. Safety syringes segment held the largest share of around 64.5% in 2023 and is anticipated to witness a significant growth over the forecast period, owing to the various advantages, such as safety and easy to use, associated with this product.
• On the basis of application, the therapeutic injection segment held the largest market share of around 86.2% in 2023, owing to the increasing awareness towards blood donation and high prevalence of diseases such as HIV infection, tuberculosis malaria, and dengue in the country.
• California disposable syringes market is expected to witness the fastest growth rate over the forecast period. Factors that can be attributed to market growth include growing geriatric population, increasing number of surgeries, and rising expenditure on healthcare.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation And Scope
  • 1.1.1 Product
  • 1.1.2 Application
  • 1.1.3 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database:
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.7.1 Commodity Flow Analysis (Model 1)
    • 1.7.1.1 Approach 1: Commodity Flow Approach
  • 1.7.2 Volume Price Analysis (Model 2)
    • 1.7.2.1 Approach 2: Volume Price Analysis
• 1.7 List Of Secondary Sources
• 1.8 List Of Primary Sources
• 1.9 List Of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective - 1
  • 1.10.2 Objective - 2
  • 1.10.3 Objective - 3
  • 1.10.4 Objective - 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Competitive Insights

Chapter 3 Disposable Syringes Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 User Perspective Analysis
  • 3.3.1 Consumer Behavior Analysis
  • 3.3.2 Market Influencer Analysis
• 3.4 List Of Key End Users
• 3.5 Market Dynamics
  • 3.5.1 Market Driver Analysis
    • 3.5.1.1 Increase In The Prevalence Of Chronic Diseases
    • 3.5.1.2 Increase In The Number Of Surgical Procedures
    • 3.5.1.3 Impact Of Covid-19 Outbreak
    • 3.5.1.4 Increasing Initiatives By Governments And Organizations
  • 3.5.2 Market Restraints Analysis
    • 3.5.2.1 Stringent Government Regulations
    • 3.5.2.2 Product Recalls
• 3.6 Disposable Syringes: Market Analysis Tools
  • 3.6.1 Industry Analysis - Porter's Five Forces
  • 3.6.2 Swot Analysis, By Pest
• 3.7 Impact Of Covid-19 On Market & Post Pandemic Insights

Chapter 4 U.S. Disposable Syringes Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

• 4.1 Definition And Scope
• 4.2 Product Market Share Analysis, 2023 & 2030
• 4.3 Segment Dashboard
• 4.4 U.S. Disposable Syringes Market, By Product, 2018 To 2030
• 4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
  • 4.5.1 Conventional Syringes
    • 4.5.1.1 Conventional Syringes Market, 2018 - 2030 (USD Million)
  • 4.5.2 Safety Syringes
    • 4.5.2.1 Safety Syringes Market, 2018 - 2030 (USD Million)
    • 4.5.2.1.1 Retractable Safety Syringes
    • 4.5.2.1 1.1 Retractable Safety Syringes Market, 2018 - 2030 (USD Million)
    • 4.5.2.1.2 Non-retractable Safety Syringes
    • 4.5.2.1.2.1 Non-retractable Safety Syringes Market, 2018 - 2030 (USD Million)

Chapter 5 U.S. Disposable Syringes Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

• 5.1 Definition And Scope
• 5.2 Application Market Share Analysis, 2023 & 2030
• 5.3 Segment Dashboard
• 5.4 U.S. Disposable Syringes Market, By Application, 2018 To 2030
• 5.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
  • 5.5.1 Immunization Injections
    • 5.5.1.1 Immunization Injections Market, 2018 - 2030 (USD Million)
  • 5.5.2 Therapeutic Injections
    • 5.5.2.1 Therapeutic Injections Market, 2018 - 2030 (USD Million)

Chapter 6 U.S. Disposable Syringes Market - Competitive Analysis

• 6.1 Recent Developments & Impact Analysis, By Key Market Participants
• 6.2 Company Categorization
  • 6.2.1 Innovators
  • 6.2.2 Market Leaders
• 6.3 Vendor Landscape
  • 6.3.1 Key Company Market Share Analysis, 2021
  • 6.3.2 Major Deals And Strategic Alliances
    • 6.3.2.1 New Product Launch
    • 6.3.2.2 Expansion
    • 6.3.2.3 Acquistion
  • 6.3.3 Market Entry Strategies
• 6.4 Company Profiles
  • 6.4.1 Medtronic
    • 6.4.1.1 Company Overview
    • 6.4.1.2 Financial Performance
    • 6.4.1.3 Product Benchmarking
    • 6.4.1.4 Strategic Initiatives
  • 6.4.2 Nipro Corporation
    • 6.4.2.1 Company Overview
    • 6.4.2.2 Financial Performance
    • 6.4.2.3 Product Benchmarking
    • 6.4.2.4 Strategic Initiatives
  • 6.4.3 Fresenius Kabi Ag
    • 6.4.3.1 Company Overview
    • 6.4.3.2 Financial Performance
    • 6.4.3.3 Product Benchmarking
    • 6.4.3.4 Strategic Initiatives
  • 6.4.4 Baxter International, Inc.
    • 6.4.4.1 Company Overview
    • 6.4.4.2 Financial Performance
    • 6.4.4.3 Product Benchmarking
    • 6.4.4.4 Strategic Initiatives
  • 6.4.5 Braun Medical, Inc.
    • 6.4.5.1 Company Overview
    • 6.4.5.2 Financial Performance
    • 6.4.5.3 Product Benchmarking
    • 6.4.5.4 Strategic Initiatives
  • 6.4.6 Becton, Dickinson And Company (Bd)
    • 6.4.6.1 Company Overview
    • 6.4.6.2 Financial Performance
    • 6.4.6.3 Product Benchmarking
    • 6.4.6.4 Strategic Initiatives
  • 6.4.7 Flextronics International Vita Needle Company
    • 6.4.7.1 Company Overview
    • 6.4.7.2 Financial Performance
    • 6.4.7.3 Product Benchmarking
    • 6.4.7.4 Strategic Initiatives
  • 6.4.8 Terumo Corporation
    • 6.4.8.1 Company Overview
    • 6.4.8.2 Financial Performance
    • 6.4.8.3 Product Benchmarking
    • 6.4.8.4 Strategic Initiatives
  • 6.4.9 Novo Nordisk
    • 6.4.9.1 Company Overview
    • 6.4.9.2 Financial Performance
    • 6.4.9.3 Product Benchmarking
    • 6.4.9.4 Strategic Initiatives
  • 6.4.10 Ultimed, Inc.
    • 6.4.10.1 Company Overview
    • 6.4.10.2 Financial Performance
    • 6.4.10.3 Product Benchmarking
    • 6.4.10.4 Strategic Initiatives
  • 6.4.11 Henke-sass, Wolf
    • 6.4.11.1 Company Overview
    • 6.4.11.2 Financial Performance
    • 6.4.11.3 Product Benchmarking
  • 6.4.12 Retractable Technologies, Inc.
    • 6.4.12.1 Company Overview
    • 6.4.12.2 Financial Performance
    • 6.4.12.3 Product Benchmarking
    • 6.4.12.4 Strategic Initiatives